Drug and Medication Analysis & Statistics, January 2013 (p30)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

871-910 of about 4 100 reports

Purchase Reports From Reputable Market Research Publishers

 Gigantism Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Gigantism Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Gigantism- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States, World
 Glioma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Glioma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Glioma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States, World
 Growth Hormone Deficiency Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Growth Hormone Deficiency Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Growth Hormone Deficiency- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Drug and Medication
  • Countries : United States
 Hospital Acquired Pneumonia (HAP) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hospital Acquired Pneumonia (HAP) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Hospital Acquired Pneumonia (HAP)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III ...

  • Industries : Drug and Medication
  • Countries : United States
 Radiation Induced Nausea and Vomiting (RINV) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Radiation Induced Nausea and Vomiting (RINV) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Radiation Induced Nausea and Vomiting (RINV)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ...

  • Industries : Drug and Medication
  • Countries : United States
2014 Deep Research Report on Global and China Progesterone Industry

2014 Deep Research Report on Global and China Progesterone Industry

  • $ 2 200
  • Industry report
  • July 2014
  • by QY Research Group

Summary The "2014 Deep Research Report on Global and China Progesterone Industry" is a professional and in-depth study on the current state of the Progesterone industry in Global and China. The report ...

  • Industries : Drug and Medication
  • Countries : China, World
Analgesics Market Analysis in New Zealand

Analgesics Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Acetaminophen accounted for 39% of analgesics current retail value sales in 2011. In addition to falling sales within acetaminophen, aspirin has also reached a very high level of maturity. Euromonito ...

  • Industries : Drug and Medication
  • Countries : New Zealand
NRT Smoking Cessation Aids Market Analysis in New Zealand

NRT Smoking Cessation Aids Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

One of the biggest changes to tobacco excise taxation over the review period occurred during 2010, when the government implemented a range of excise tax increases levied on cigarettes, cigars, cigarillos ...

  • Industries : Drug and Medication, Tobacco
  • Countries : New Zealand
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

This followed an agreement by the cabinet in September 2009 to reclassify these two drugs considering the fact they are active ingredients used in the manufacture of the Class A controlled drug methamphetamine. ...

  • Industries : Drug and Medication
  • Countries : New Zealand
MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America
2014 Deep Research Report on Global and China Benzoyl Peroxide Industry

2014 Deep Research Report on Global and China Benzoyl Peroxide Industry

  • $ 2 200
  • Industry report
  • July 2014
  • by QY Research Group

Summary 2014 Deep Research Report on Global and China Benzoyl Peroxide Industry was professional and depth research report on Global and China Benzoyl Peroxide industry. The report firstly introduced Benzoyl ...

  • Industries : Drug and Medication
  • Countries : China, World
Glucocorticoid Receptor II (GR-II) Antagonists -Pipeline Insights, 2014

Glucocorticoid Receptor II (GR-II) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Drug and Medication
Adenosine A1 Receptor Agonists -Pipeline Insights, 2014

Adenosine A1 Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A1 Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication
Adenosine A1 Receptor Antagonists -Pipeline Insights, 2014

Adenosine A1 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A1 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Adenosine A2 Receptor Antagonists -Pipeline Insights, 2014

Adenosine A2 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A2 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Adenosine A2A Receptor Agonists -Pipeline Insights, 2014

Adenosine A2A Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A2A Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Adenosine A2A Receptor Antagonists -Pipeline Insights, 2014

Adenosine A2A Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A2A Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Adenosine A2B Receptor Antagonists -Pipeline Insights, 2014

Adenosine A2B Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A2B Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Adenosine A3 Receptor Agonists -Pipeline Insights, 2014

Adenosine A3 Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A3 Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication
Adenosine A3 Receptor Antagonists -Pipeline Insights, 2014

Adenosine A3 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine A3 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Adenosine Antagonists -Pipeline Insights, 2014

Adenosine Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Adenosine Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Aldose Reductase Inhibitors -Pipeline Insights, 2014

Aldose Reductase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aldose Reductase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Aldosterone Antagonists -Pipeline Insights, 2014

Aldosterone Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aldosterone Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Androgen Agonists -Pipeline Insights, 2014

Androgen Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Androgen Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Androgen Antagonists -Pipeline Insights, 2014

Androgen Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Androgen Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2014

Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin Converting Enzyme (ACE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Cannabinoid Agonists -Pipeline Insights, 2014

Cannabinoid Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2014

Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Receptor Type 1 (CB1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2014

Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Receptor Type 1 (CB1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2014

Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Receptor Type 2 (CB2) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication

64 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Icon Group

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.